Fusion Antibodies plc (AIM:FAB)

Fusion Antibodies Ratios and Metrics

Market cap in millions GBP. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct 3, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	18	6	4	10	16	40
Market Cap Growth	477.56%	80.40%	-64.29%	-35.83%	-61.18%	91.59%
Enterprise Value	18	6	3	9	14	37
Last Close Price	0.16	0.06	0.04	0.39	0.60	1.57
PS Ratio	9.11	3.28	3.15	3.45	3.25	9.65
PB Ratio	26.76	9.64	2.00	8.92	4.24	8.47
P/TBV Ratio	26.76	9.64	2.00	8.92	4.24	8.47
EV/Sales Ratio	8.94	3.08	2.76	3.15	2.87	8.95
Debt / Equity Ratio	0.03	0.03	0.02	0.07	0.02	0.05
Asset Turnover	1.05	1.05	0.51	0.83	0.89	0.70
Inventory Turnover	4.21	4.21	2.36	4.14	4.38	5.22
Quick Ratio	1.22	1.22	2.89	1.01	2.54	3.48
Current Ratio	2.02	2.02	3.87	1.92	3.55	4.72
Return on Equity (ROE)	-139.16%	-139.16%	-152.68%	-108.01%	-28.47%	-60.66%
Return on Assets (ROA)	-57.64%	-57.64%	-63.36%	-51.85%	-15.41%	-13.15%
Return on Capital (ROIC)	-85.45%	-85.45%	-93.61%	-73.07%	-18.97%	-15.35%
Earnings Yield	-9.57%	-26.55%	-62.24%	-25.92%	-7.69%	-7.21%
FCF Yield	-7.68%	-21.30%	-49.52%	-18.65%	-3.77%	-3.73%
Buyback Yield / Dilution	-72.58%	-72.58%	-113.55%	-0.27%	-1.91%	-15.24%

Updated Mar 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.